Literature DB >> 16389345

Treatment options for clinical stage 1 testis cancer.

A I Sagalowsky1.   

Abstract

Entities:  

Year:  2000        PMID： 16389345      PMCID： PMC1312235          DOI： 10.1080/08998280.2000.11927709

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  5 in total

1.  Risk of second malignant neoplasms among long-term survivors of testicular cancer.

Authors:  L B Travis; R E Curtis; H Storm; P Hall; E Holowaty; F E Van Leeuwen; B A Kohler; E Pukkala; C F Lynch; M Andersson; K Bergfeldt; E A Clarke; T Wiklund; G Stoter; M Gospodarowicz; J Sturgeon; J F Fraumeni; J D Boice
Journal:  J Natl Cancer Inst       Date:  1997-10-01       Impact factor: 13.506

2.  Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer.

Authors:  J W Moul; P B Snow; E B Fernandez; P D Maher; I A Sesterhenn
Journal:  J Urol       Date:  1995-05       Impact factor: 7.450

Review 3.  Current considerations in the diagnosis and initial treatment of testicular cancer.

Authors:  A I Sagalowsky
Journal:  Compr Ther       Date:  1994

4.  Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.

Authors:  B P Hermans; C J Sweeney; R S Foster; L E Einhorn; J P Donohue
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

5.  Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome.

Authors:  G Janetschek; A Hobisch; R Peschel; A Hittmair; G Bartsch
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.